Search Results
587 items found for " Breast cancer cell pools"
Programs (1)
- Advanced data analysis for GPCR pharmacology
ability to perform, understand, and communicate GPCR pharmacology data analysis to a high level, as well
Posts (315)
- GASP1 enhances malignant phenotypes of breast cancer cells and decreases their response to...
September 2022 GASP1 enhances malignant phenotypes of breast cancer cells and decreases their response Here, we demonstrated that GASP1 was highly expressed in breast cancers, and patients harboring altered cancer cells, such as inhibition of cell proliferation, colony formation, migration, invasion and xenograft Besides, we found that GASP1 knockout obviously improved the response of breast cancer cells to paclitaxel Collectively, this study demonstrates that GASP1 enhances malignant behaviors of breast cancer cells
- Lack of Oestrogen Receptor Expression in Breast Cancer Cells Does Not Correlate with Kisspeptin...
September 2022 Lack of Oestrogen Receptor Expression in Breast Cancer Cells Does Not Correlate with Kisspeptin Signalling and Migration "Kisspeptin is an anti-metastatic mediator in many cancer types, acting through However, controversy remains regarding its role in breast cancer since both pro- and anti-metastatic In KISS1R overexpressing triple-negative breast cancer (TNBC) cells, stimulation has been associated further investigation and may enable further stratification of the ability of kisspeptin to influence breast
- High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and...
September 2022 High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and predicts poor patient outcomes "Triple-negative breast cancer (TNBC) is a particularly aggressive It is generally considered that TNBC is an estrogen-independent breast cancer, while a new estrogen receptor significantly linked to the worse survival in patients with lymph node metastasis, TNM stage III as well
Other Pages (271)
- Molecular characterization of breast cancer cell pools with normal or reduced ability to respond to progesterone: a study based on RNA-seq
< GPCR News < GPCRs in Oncology and Immunology Molecular characterization of breast cancer cell pools cancer cells. cancer cells. cancer cells. cancer cell pools , progesterone response , RNA-seq , CRISPR/Cas9 , estrogen receptor alpha , gene expression
- Vasoactive intestinal peptide receptor 2 signaling promotes breast cancer cell proliferation by enhancing the ERK pathway
cancer cell proliferation by enhancing the ERK pathway Published date January 2, 2023 Abstract “ Vasoactive However, the pathophysiological role of increased VIPR2 in the proliferation of breast cancer cells remains In this study, we found that VIPR2 overexpression in MCF-7 and MDA-MB-231 cells, human breast cancer Increased VIPR2 also exacerbated intraperitoneal proliferation of breast cancer MDA-MB-231 cells in a cancer , Cell proliferation , ERK , GPCR , VIPR2 , cAMP.
- Lactate receptor GPR81 drives breast cancer growth and invasiveness through regulation of ECM properties and Notch ligand DLL4
< GPCR News < GPCRs in Oncology and Immunology Lactate receptor GPR81 drives breast cancer growth and Methods: GPR81 was stably knocked down (KD) in MCF-7 human breast cancer cells which were subjected to Key findings were additionally studied in other breast cancer cell lines and in mammary epithelial cells lactate and 3D growth in breast cancer spheroids. Conclusions: GPR81 supports breast cancer aggressiveness, and in MCF-7 cells, this occurs at least in